A state-of-the-art biologics manufacturing facility, established with an investment of approximately ₹1,000 crore, was inaugurated at Borpatla Village, Hatnoora Mandal, Sangareddy District. The facility is expected to manufacture advanced biologic medicines for the treatment of cancer and other life-threatening diseases while creating around 1,500 employment opportunities. This landmark project strengthens Sangareddy’s position as a major pharmaceutical and biotechnology hub, contributing to Telangana’s industrial growth and enhancing India’s presence in the global life sciences sector.